442 9. Lanza RP, Hayes JL, Chick WL. Encapsulated cell technology. Nature. 1996;14:1107–11. 10. de Vos P, Faas MM, Strand B, et al. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials. 2006;27 (32):5603–17. 11. Teramura Y, Iwata H. Bioartificial pancreas- microencapsulation and conformal coating of islet of langerhans. Adv Drug Deliv Rev. 2010;62(7–8):827–40. 12. Eberhard D, Lammert E. The pancreatic β-cell in the islet and organ community. Curr Opin Genet Dev. 2009;19(5):469–75. 13. Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and β cell proliferation. Dev Cell. 2006;10(3):397–405. 14. Nikolova G, Strilic B, Lammert E. The vascular niche and its basement membrane. Trends Cell Biol. 2007;17(1):19–25. 15. Otonkoski T, Banerjee M, Korsgren O, et al. Unique basement membrane structure of human pancreatic islets: implications for β-cell growth and differentiation. Diabetes Obes Metabol. 2008;10:119–27. 16. Virtanen I, Banerjee M, Palgi J, et al. Blood vessels of human islets of langerhans are surrounded by a double basement membrane. Diabetologia. 2008;51(7):1181–91. 17. Wojtusciszyn A, Armanet M, Morel P, et al. Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts. Diabetologia. 2008;51(10):1843–52. 18. Gautam D, Han S-J, Hamdan FF, et al. A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metabol. 2006;3(6):449–61. 19. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A. 2010;107(37):16009–12. 20. Huypens P, Ling Z, Pipeleers D, et al. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia. 2000;43(8):1012–101. 21. Bosco D, Armanet P, Morel P, et al. Unique arrangement of alpha cells and beta cells in human islets of Langerhans. Diabetes. 2010;59(5):1202–10. 22. Ahrén B. Autonomic regulation of islet hormone secretion–implica- tions for health and disease. Diabetologia. 2000;43(4):393–410. 23. Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Investig. 2007;117(1):24–32. 24. Wang RN, Rosenberg L. Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol. 1999;163:181–90. 25. Vajkoczy P, Olofsson AM, Lehr HA, et al. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol. 1995;146(6):1397–405. 26. Menger MD, Vajkoczy P, Leiderer R, et al. Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts. J Clin Investig. 1992;90(4):1361–9. 27. Hirshberg B. Histopathological study of intrahepatic islets trans- planted in the nonhuman primate model using edmonton protocol immunosuppression. J Clin Endocrinol Metab. 2002;87(12):5424– 9. 28. Vasir B, Aiello LP, Yoon KH, et al. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes. 1998;47(12):1894–903. 29. Lai Y, Schneider D, Kidszun A, et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation. 2005;79(11):1530–6. 30. Brissova M, Shostak A, Shiota M, et al. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes. 2006;55(11):2974–85. Curr Diab Rep (2011) 11:434–444 31. Bosco D, Meda P, Halban PA, et al. Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes. 2000;49(2):233–43. 32. Hammar E, Parnaud G, Bosco D, et al. Extracellular matrix protects pancreatic β-cells against apoptosis. Diabetes. 2004;53 (8):2034–41. 33. Parnaud G, Hammar E, Ribaux P, et al. Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix. Mol Endocrinol. 2009;23(8):1264–71. 34. Contreras J. Peripheral mobilization of recipient bone marrow- derived endothelial progenitor cells enhances pancreatic islet revascularization and engraftment after intraportal transplantation. Surgery. 2003;134(2):390–8. 35. Nyqvist D, Köhler M, Wahlstedt H, et al. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes. 2005;54(8):2287–93. 36. Miller R, Cirulli V, Diaferia GR, et al. Switching-on survival and repair response programs in islet transplants by bone marrow-derived vasculogenic cells. Diabetes. 2008;57(9): 2402–12. 37. Johansson U, Elgue G, Nilsson B, et al. Composite islet- endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. Am J Transplant. 2005;5 (11):2632–9. 38. Ianus A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Investig. 2003;111(6):843–50. 39. Hess D, Li L, Martin M, et al. Bone marrow–derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003;21(7):763–70. 40. Sordi V, Piemonti L. The contribution of hematopoietic stem cells to beta-cell replacement. Curr Diabetes Rep. 2009;9 (2):119–24. 41. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchy- mal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106(2):419–27. 42. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A. 2006;103(46):17438–43. 43. Ezquer F, Ezquer M, Parrau D, et al. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant. 2008;14(6):631–40. 44. Figliuzzi M, Cornolti R, Perico N, et al. Bone marrow–derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc. 2009;41(5):1797–800. 45. Park KS, Kim YS, Kim JH, et al. Influence of human allogenic bone marrow and cord blood–derived mesenchymal stem cell secreting trophic factors on ATP (adenosine-5′-triphosphate)/ADP (adenosine-5′-diphosphate) ratio and insulin secretory function of isolated human islets from cadaveric donor. Transplant Proc. 2009;41(9):3813–8. 46. Lu Y, Jin X, Chen Y, et al. Mesenchymal stem cells protect islets from hypoxia/reoxygenation-induced injury. Cell Biochem Funct. 2010;28(8):637–43. 47. Jacobson S, Kumagai-Braesch M, Tibell A, et al. Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts. Ann N YAcad Sci. 2008;1150(1):213–6. 48. Ding Y, Xu D, Feng G, et al. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and −9. Diabetes. 2009;58 (8):1797–806. 49. Madec AM, Mallone R, Afonso G, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia. 2009;52(7):1391–9.